NCT02611453View on ClinicalTrials.gov

Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
CholedocholithiasisBile Duct DiseasesBile Duct Carcinoma
Interventions
OTHER

"Air contrast cholangiography using carbon dioxide gas"

Carbon dioxide (CO2) will be injected into the biliary tree (which is already exposed to CO2 during routine ERCP) and images will be obtained by using fluoroscopy and digital subtraction imaging (a specific setting on certain fluoroscopy tables).

Trial Locations (1)

22908

University of Virginia Health System, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT02611453 - Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP | Biotech Hunter | Biotech Hunter